Literature DB >> 2983800

Atypical characteristics of the beta-adrenoceptor mediating cyclic AMP generation and lipolysis in the rat adipocyte.

D Bojanic, J D Jansen, S R Nahorski, J Zaagsma.   

Abstract

The characteristics of the rat epidydimal adipocyte beta-adrenoceptor have been examined using lipolysis and cyclic AMP accumulation in adipocytes as well as adenylate cyclase activity in fat cell membranes. The pA2 values corrected for binding to bovine serum albumin of the selective antagonists betaxolol (beta 1-selective) and ICI 118.551 (beta 2-selective) against noradrenaline or fenoterol-stimulated lipolysis were indicative of an atypical beta-adrenoceptor associated with the lipolytic response. Antagonism of isoprenaline-stimulated cyclic AMP accumulation in whole cells and adenylate cyclase activity in membranes yielded pA2 values to betaxolol, ICI 118.551 and (-)-propranolol, which suggested that the atypical beta-adrenoceptor was coupled to adenylate cyclase. Comparisons of the Ki values obtained in binding studies using [125I]-cyanopindolol with pA2 values obtained in adenylate cyclase experiments suggest that the typical beta 1-receptor identified with radioligand binding studies is not the only receptor site mediating stimulation of adenylate cyclase activity and lipolysis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2983800      PMCID: PMC1987202     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  Isoprenaline antagonism of cardioselective beta-adrenergic receptor blocking agents on human and rat adipocytes.

Authors:  H H Harms; J Van der Meer
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

2.  A simple and sensitive saturation assay method for the measurement of adenosine 3':5'-cyclic monophosphate.

Authors:  B L Brown; J D Albano; R P Ekins; A M Sgherzi
Journal:  Biochem J       Date:  1971-02       Impact factor: 3.857

3.  Selective metabolic and cardiovascular beta receptor antagonism in the rat.

Authors:  H C Stanton
Journal:  Arch Int Pharmacodyn Ther       Date:  1972-04

4.  Adenosine release from isolated fat cells and its significance for the effects of hormones on cyclic 3',5'-AMP levels and lipolysis.

Authors:  U Schwabe; R Ebert; H C Erbler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

5.  Beta-adrenoceptor studies. III. On the beta-adrenoceptors in rat adipose tissue.

Authors:  H H Harms; J Zaagsma; B Van der Wal
Journal:  Eur J Pharmacol       Date:  1974-01       Impact factor: 4.432

6.  Studies on receptor-mediated activation of adenylyl cyclases. IV. Characteristics of the adrenergic receptor coupled to myocardial adenylyl cyclase: stereospecificity for ligands and determination of apparent affinity constants for beta-blockers.

Authors:  A J Kaumann; L Birnbaumer
Journal:  J Biol Chem       Date:  1974-12-25       Impact factor: 5.157

7.  Differentiation of receptor systems activated by sympathomimetic amines.

Authors:  A M Lands; A Arnold; J P McAuliff; F P Luduena; T G Brown
Journal:  Nature       Date:  1967-05-06       Impact factor: 49.962

8.  A submicromolar assay for nonpolar acids in plasma and depot fat.

Authors:  H Ko; M E Royer
Journal:  Anal Biochem       Date:  1967-08       Impact factor: 3.365

9.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

10.  Adenosine 3',5'-monophosphate in biological materials. II. The measurement of adenosine 3',5'-monophosphate in tissues and the role of the cyclic nucleotide in the lipolytic response of fat to epinephrine.

Authors:  R W Butcher; R J Ho; H C Meng; E W Sutherland
Journal:  J Biol Chem       Date:  1965-11       Impact factor: 5.157

View more
  11 in total

Review 1.  Biotechnology of beta-adrenergic receptors.

Authors:  A D Strosberg
Journal:  Mol Neurobiol       Date:  1990 Fall-Winter       Impact factor: 5.590

2.  Direct evidence for the atypical nature of functional beta-adrenoceptors in rat adipocytes.

Authors:  C Hollenga; J Zaagsma
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

3.  β(3) Receptors: Role in Cardiometabolic Disorders.

Authors:  Shraddha V Bhadada; Bhoomika M Patel; Anita A Mehta; Ramesh K Goyal
Journal:  Ther Adv Endocrinol Metab       Date:  2011-04       Impact factor: 3.565

4.  The beta-adrenoceptors mediating relaxation of rat oesophageal muscularis mucosae are predominantly of the beta 3-, but also of the beta 2-subtype.

Authors:  R E de Boer; F Brouwer; J Zaagsma
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

5.  A novel action of isoproterenol to inactivate a cardiac K+ current is not blocked by beta and alpha adrenergic blockers.

Authors:  C Tromba; I S Cohen
Journal:  Biophys J       Date:  1990-09       Impact factor: 4.033

6.  Characterization of propranolol-resistant (-)-[125I]-cyanopindolol binding sites in rat soleus muscle.

Authors:  S J Roberts; P Molenaar; R J Summers
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

7.  A response to isoprenaline unrelated to alpha- and beta-adrenoceptor agonism.

Authors:  R A Bond; D E Clarke
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

8.  Mediation of most atypical effects by species homologues of the beta 3-adrenoceptor.

Authors:  N Blin; C Nahmias; M F Drumare; A D Strosberg
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

9.  Relationship between lipolysis and cyclic AMP generation mediated by atypical beta-adrenoceptors in rat adipocytes.

Authors:  C Hollenga; F Brouwer; J Zaagsma
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

10.  The antinociceptive action of some beta-adrenoceptor agonists in mice.

Authors:  G A Bentley; J Starr
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.